Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
NAVB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 2.54%53.730.9%$2578.87m
JNJJohnson & Johnson -2.37%155.960.7%$1216.03m
MRKMerck & Co., Inc. 0.00%74.890.7%$1134.23m
LLYEli Lilly & Co. -2.55%248.341.1%$731.87m
BMYBristol-Myers Squibb Co. -1.85%53.631.0%$692.49m
ABBVAbbVie, Inc. -1.41%115.241.9%$609.56m
AZNAstraZeneca Plc -1.26%54.831.0%$288.05m
NVSNovartis AG -0.72%79.690.2%$175.76m
GSKGlaxoSmithKline Plc -0.56%41.130.2%$174.09m
VTRSViatris, Inc. -1.68%12.310.0%$138.06m
DRNADicerna Pharmaceuticals, Inc. -0.18%38.010.3%$135.01m
BFRIBiofrontera, Inc. -15.63%5.990.0%$129.02m
RPRXRoyalty Pharma Plc -3.80%39.770.1%$117.73m
RGENRepligen Corp. -1.61%286.506.7%$114.53m
PTPIPetros Pharmaceuticals, Inc. -28.50%2.860.0%$96.83m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.